Cibinqo

Generic name: Abrocitinib
Dosage form: tablets (50mg, 100mg, 200mg)
Drug class: Selective immunosuppressants

Usage of Cibinqo

Cibinqo (abrocitinib) tablets are used to treat eczema (atopic dermatitis) that is moderate to severe in patients who have not found relief with topical medications or are not able to use them. Cibinqo is a once-a-day tablet that can be used by adults and children over 12 years of age.

Eczema may be caused by an overactive immune system leading to inflammation which causes dry, itchy skin and eczema flare-ups. Janus kinase (JAK) is an enzyme thought to play a role in skin inflammation. Cibinqo works by blocking the JAK1 activity, decreasing inflammation which helps reduce itching and improves skin condition.

Cibinqo belongs to a class of medications called JAK inhibitors (Janus kinase inhibitors).

Cibinqo received FDA-approval on January 14, 2022.

Cibinqo side effects

Get emergency medical help if you have signs of an allergic reaction to Cibinqo: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Call your doctor at once if you have:

worsening eye problems - eye pain, or changes in your vision;

signs of an infection - fever, sweating, or chills, muscle aches, cough or shortness of breath, weight loss, painful skin or sores on your body, diarrhea or stomach pain, burning when you urinate or urinating more often than usual, feeling very tired;

heart attack symptoms - chest pain or pressure, pain spreading to your jaw or shoulder, nausea, sweating;

signs of a blood clot - sudden numbness or weakness on one side of the body, chest pain, problems with vision or speech, pain or swelling in one leg;

signs of a stroke - sudden numbness or weakness, severe headache, slurred speech, problems with vision or balance; or

low blood cell counts - fever, chills, tiredness, mouth sores, skin sores, easy bruising, unusual bleeding, pale skin, cold hands and feet, feeling light-headed or short of breath.

Common Cibinqo side effects may include:

flu-like symptoms, tingly or painful blistering rash on one side of your body;

abnormal lab results;

pain and burning when you urinate, painful urination;

nausea, vomiting, stomach pain;

mouth and throat pain;

skin infection, rash;

cold sores;

high blood pressure;

pimples;

headache;

dizziness; or

tiredness.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Cibinqo

You should not use Cibinqo with other medicines that prevent blood clots during the first 3 months of treatment. You can take aspirin (up to a dose of 81 mg each day) during this time if prescribed by your doctor.

To make sure Cibinqo is safe for you, tell your doctor if you:

have an infection;

are a current or past smoker;

have had a stroke, a heart attack, or other heart problems;

have kidney or liver problems;

have low platelet or white blood cell counts;

have eye problems, such as cataracts or retinal detachment; or

have recently received or are scheduled to receive a vaccine.

Tell your doctor if you've had or been exposed to tuberculosis, or if you recently traveled. Some infections are more common in certain parts of the world, and you may have been exposed during travel.

Pregnancy

It is not known if Cibinqo will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant. If you are pregnant, your name may be listed on a pregnancy registry to track the effects of abrocitinib on the baby.

It may be harder for you to get pregnant while you are using Cibinqo.

Breastfeeding

Ask a doctor if it is safe to breastfeed while using this medicine.

Relate drugs

How to use Cibinqo

Usual Cibinqo Dose for Atopic Dermatitis:

Dose: 100 mg orally once a day.

Maximum dose: 200 mg/day.

Duration of therapy: If no adequate response is achieved with 100 mg/day after 12 weeks, the dose can be increased to 200 mg/day. Discontinue if inadequate response is seen after this dosage increase.

Comments: This drug should not be used in combination with other Janus kinase (JAK) inhibitors, biologic immunomodulators, or immunosuppressants. This drug can be used with or without topical corticosteroids.

Use: Refractory moderate to severe atopic dermatitis in patients 12 years of age and older, whose condition has not been adequately controlled with other systemic drug products.

Cibinqo tablets are available as: 50mg, 100mg, 200mg.

Click the link below for more detailed dose information.

Warnings

Cibinqo may increase your risk of certain cancers, such as lymphoma, lung cancer, and skin cancer. Ask your doctor about your risk.

Cibinqo is not recommended for use in combination with other JAK inhibitors, biologic immunomodulators, or with other immunosuppressants.

Cibinqo may cause serious side effects. Call your doctor at once if you have:

signs of a blood clot - sudden numbness or weakness on one side of the body, chest pain, problems with vision or speech, pain or swelling in one leg;

heart attack symptoms - chest pain or pressure, pain spreading to your jaw or shoulder, nausea, sweating;

signs of a stroke - sudden numbness or weakness, severe headache, slurred speech, problems with vision or balance; or

signs of an infection - fever, sweating, or chills, cough or shortness of breath, weight loss, burning when you urinate or urinating more often than usual, or feeling very tired.

What other drugs will affect Cibinqo

Sometimes it is not safe to use certain medicines at the same time. Some drugs can affect your blood levels of other drugs you use, which may increase side effects or make the medicines less effective.

Cibinqo is not recommended for use in combination with other JAK inhibitors, biologic immunomodulators, or with other immunosuppressants.

Tell your doctor about all your other medicines, especially:

digoxin;

aspirin; or

medicines that prevent blood clots.

This list is not complete. Other drugs may interact with abrocitinib, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

Popular FAQ

Janus kinase (JAK) inhibitors are a group of medicines that help block immune system signals in the body that can lead to swelling (inflammation) and pain in conditions like rheumatoid arthritis, ulcerative colitis, and psoriatic arthritis. They work by blocking enzymes that lead to overactivity of the immune system. Continue reading

List of JAK inhibitors approved in the United States include: Cibinqo (abrocitinib) Inrebic (fedratinib) Jakafi (ruxolitinib) Litfulo (ritlecitinib) Ojjaara (momelotinib) Olumiant (baricitinib) Opzelura (ruxolitinib) Rinvoq (upadacitinib) Vonjo (pacritinib) Xeljanz (tofacitinib) Continue reading

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.